Mounjaro (tirzepatide) is a once-weekly injectable medication approved in the UK for weight management in adults with obesity or overweight conditions. It combines dual action by mimicking the GLP-1 and GIP hormones, effectively reducing appetite and improving blood sugar control. Clinical trials have shown significant weight reduction, with some participants losing up to 22.5% of their body weight. For optimal results, Mounjaro should be used alongside a reduced-calorie diet and increased physical activity. It is available through private prescriptions. https://synergypharmacys.co.uk/mounjaro-tirzepatide-injection-for-weight-management/